Can the CBD compound extracted from cannabis can control mental disorders?

According to a new study, Cannabidiol (CBD), an extract derived from cannabis, has been shown to reduce mental symptoms by reducing abnormal brain function.

King's College researchers have for the first time found that CBD - a non-toxic compound in cannabis , can reduce mental symptoms. The discovery was published Wednesday in American Medical Association Psychiatry.

"Currently the young people at risk of mental disorders around the world are in desperate need of a safe treatment for their disease" - Dr. Sagnik Bhattacharyya, a researcher at the Institute of Psychiatry, Psychology and Neurology at King's College, said in a press release. "One of the main advantages of cannabidiol (CBD) is that it is safe and seems to be absorbed well, which makes CBD an ideal treatment."

CBD - non-toxic compound in cannabis, can reduce mental symptoms.

In June, the US Food and Drug Administration approved for the first time the use of cannabidiol for the treatment of seizures involving two rare and severe forms of seizures: Lennox-Gastaut syndrome and Dravet syndrome. .

According to Dr. Bhattacharyya: "At the present time, the treatment for people with mental disorders is still using drugs invented in the 1950s and there is an unfortunate fact that they do not work. for everyone ".

The study was conducted with the participation of 52 people aged between 20 and 33 years, 33 of whom were not diagnosed with mental disorders but experienced mental symptoms and 19 others were strong normal health. One dose of cannabidiol was given to 16 participants, while another 17 received placebo.

MRI magnetic resonance imaging has been used in the process when participants perform memory-related exercises that require the participation of three regions of the brain known to be responsible for the symptoms of confusion. Psychosis: temporal lobes, frontal lobes and occipital lobes.

Brain activity in participants who are at risk of mental disorders is more unusual than healthy participants. However, for 16 people at risk of mental disorders who use cannabidiol, abnormal brain activity is determined to be less serious than those with the same risk but taking placebo.

In previous studies, scientists at King's College London found that cannabidiol seems to work against tetrahydrocannabinol, or THC , the ingredient in cannabis that has the potential to give users a sense of approval.

Researchers say they are currently planning a large-scale trial through testing centers to investigate whether cannabidiol can actually treat young people at high risk of neurosis. .